Omar S. Usmani
Elite in Chronic Obstructive Pulmonary Disease (COPD)

Omar S. Usmani

London, ENG, GB 
Elite in Chronic Obstructive Pulmonary Disease (COPD)
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Omar Usmani practices in London, United Kingdom. Mr. Usmani is rated as an Elite expert by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Hypersensitivity Pneumonitis, and Allergic Rhinitis.

His clinical research consists of co-authoring 185 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 75 articles and participated in 1 clinical trial in the study of Chronic Obstructive Pulmonary Disease (COPD).

Gender
Male

Locations

London, ENG, United Kingdom
Other Locations
Brompton, ENG, United Kingdom
United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

GR Activity in Induced Sputum Macrophages, and a Change in Inflammatory Biomarkers 2-hours After a Single Dose of Either Symbicort®/Budesonide/Formoterol or in Chronic Obstructive Pulmonary Disease (COPD)
GR Activity in Induced Sputum Macrophages, and a Change in Inflammatory Biomarkers 2-hours After a Single Dose of Either Symbicort®/Budesonide/Formoterol or in Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 4
The Clinical Effect in Asthma of Inhaled Fluticasone Propionate Delivered as Monodisperse Aerosols
The Clinical Effect in Asthma of Inhaled Fluticasone Propionate Delivered as Monodisperse Aerosols
Enrollment Status: Completed
Publish Date: November 18, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

185 Total Publications

Profile of the Respimat soft mist inhaler for chronic obstructive pulmonary disease treatment: overview of its safety and efficacy.
Profile of the Respimat soft mist inhaler for chronic obstructive pulmonary disease treatment: overview of its safety and efficacy.
Journal: Expert review of medical devices
Published: August 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Usmani's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile